PEAK6’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$220K Sell
2,400
-6,900
-74% -$604K ﹤0.01% 2248
2026
Q1
$793K Sell
9,300
-1,400
-13% -$125K ﹤0.01% 1799
2025
Q4
$846K Buy
+10,700
New +$839K ﹤0.01% 1855
2025
Q3
– Sell
-3,500
Closed -$318K – 2993
2025
Q2
$318K Hold
3,500
– – ﹤0.01% 2300
2025
Q1
$328K Sell
3,500
-11,300
-76% -$1.01M ﹤0.01% 2244
2024
Q4
$1.35M Buy
+14,800
New +$1.41M ﹤0.01% 1645

Other funds holding CL

PEAK6's CL Position: Q2 2026 in Review

PEAK6 opened a new position in Colgate-Palmolive (CL) in Q2 2026: 2,884 shares worth $264K. The stake represents ﹤0.01% of the portfolio and ranks #2194 among its holdings. This is a return to the name: PEAK6 previously reported a position in CL as recently as Q4 2025.

PEAK6 first reported a position in CL in Q4 2025 and has held it in 2 quarters since. The position peaked at $619K in Q4 2025. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • PEAK6 held 2,884 shares of Colgate-Palmolive worth $264K as of Q2 2026.
  • Colgate-Palmolive was a new PEAK6 position in Q2 2026.
  • Colgate-Palmolive made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #2194 holding.
  • PEAK6 first reported a position in Colgate-Palmolive in Q4 2025 and has held it in 2 quarters since.
  • PEAK6's Colgate-Palmolive position peaked at $619K in Q4 2025.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.